₹483.05
based on 14 analysts
85.71%
Buy
7.14%
Hold
7.14%
Sell
Based on 14 analysts offering long term price targets for Fortis Healthcare Ltd. An average target of ₹525.86
Source: S&P Global Market Intelligence
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.45 % |
3 Month Return | + 8.27 % |
1 Year Return | + 44.98 % |
Market Stats | |
Previous Close | ₹487.20 |
Open | ₹486.95 |
Volume | 6.15L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹36,781.56Cr |
P/E Ratio | 61.44 |
PEG Ratio | 511.98 |
Market Cap | ₹36,781.56 Cr |
P/B Ratio | 3.49 |
EPS | 1.21 |
Organisation | Fortis Healthcare Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Fortis Healthcare Ltd
Dr. Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare Limited, has noted several unmet demands in the current budget related to healthcare and urges them to be considered in future budgets.
Fortis Healthcare Urges Govt to Prioritize Infrastructure; Ex-Dividend Trading Soon - 20 Jul, 2024
Fortis Healthcare's CEO calls for prioritizing healthcare infrastructure and implementing policies conducive to private sector investment. The company is set to trade ex-dividend on July 24, with a dividend payment of ₹1.00 per share on August 31.
Fortis Healthcare Target Price Raised by Analysts - 16 Jul, 2024
Analysts at JM Financial and Nomura have raised their target prices for Fortis Healthcare Ltd. due to the company's improving financial performance and growth prospects in the hospital industry. JM Financial has set a target price of Rs 595 while Nomura has set a target price of Rs 547, both indicating positive sentiment towards the stock.
JM Financial Initiates Coverage on Fortis Healthcare and Other Hospital Stocks - 15 Jul, 2024
JM Financial has initiated coverage on hospital stocks including Fortis Healthcare, with a buy rating and target price of Rs 595. The brokerage firm sees an upside potential of up to 48.5% for Fortis Healthcare, GPT Healthcare, and Max Healthcare.
Fortis Healthcare FY 2024 Results Show Revenue Growth - 14 Jul, 2024
Fortis Healthcare's full-year 2024 results show a revenue increase of 9.5% from the previous year, with net income up by 1.7%. However, profit margin decreased to 8.7%, driven by higher expenses. EPS increased slightly and missed analyst estimates by 1.1%. Looking ahead, revenue is forecasted to grow at an average rate of 12% p.a. for the next three years. The stock has seen a 4.1% increase in value over the past week.
Fortis Healthcare's EBITDA Margin to Improve - 12 Jul, 2024
Fortis Healthcare is expected to improve its EBITDA margin by 280 basis points YoY to 19.2%. However, its diagnostic arm Agilus may face challenges due to weaker brand recognition post-rebranding.
Fortis CEO Urges Govt to Prioritize Healthcare Infrastructure - 09 Jul, 2024
Dr Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare, has urged the Indian government to prioritize healthcare infrastructure by increasing GDP spending to 2.5% in the upcoming budget. He emphasized that transformative measures are needed to establish India as a global healthcare powerhouse.
Fortis Healthcare to Pay Dividend of Rs 1 per Share - 05 Jul, 2024
Fortis Healthcare Limited has announced a dividend payment of ₹1.00 per share on August 31st, with a yield of 0.2%. The earnings easily cover the dividend and are expected to rise by 116.9% over the next year. With a payout ratio of 5.8%, the sustainability of the dividend is comfortable. Overall, Fortis Healthcare has solid potential as a dividend stock.
Fortis Healthcare Ltd Stock Update - 02 Jul, 2024
Fortis Healthcare Ltd (NSE: FORTIS) is trading at 464.75 INR on the National Stock Exchange (NSE), experiencing a decline of 6.80 INR, or 1.44%, today.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 134.67 Cr → 178.73 Cr (in ₹), with an average increase of 24.7% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 1.69K Cr → 1.80K Cr (in ₹), with an average increase of 5.8% per quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 14.45% of holdings in Jun 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 31.17% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Global Health Ltd has given 66.4% return, outperforming this stock by 21.4%
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 239.0% return, outperforming this stock by 141.5%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 23.24% of holdings in Jun 2024 quarter
Price Dip
In the last 7 days, FORTIS stock has moved down by -0.2%
Q'1 24 | Q/Q Change | |
---|---|---|
Revenue | ₹1,785.88Cr | ↑6.32% |
Net Income | ₹203.14Cr | ↑51.34% |
Net Profit Margin | 11.37% | ↑42.30% |
2024 | Y/Y Change | |
---|---|---|
Revenue | ₹7,175.67Cr | ↑9.77% |
Net Income | ₹645.22Cr | ↑1.93% |
Net Profit Margin | 8.99% | ↓7.13% |
2024 | Y/Y Change | |
---|---|---|
Total Assets | ₹10,488.26Cr | ↓0.08% |
Total Liabilities | ₹1,401.09Cr | ↓8.62% |
2024 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹218.45Cr | ↑10.12% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 31.17% | 0.00 | |
Foreign Institutions | 23.24% | 0.00 | |
Mutual Funds | 26.51% | 0.00 | |
Retail Investors | 14.45% | 0.00 | |
Others | 4.64% | 0.00 |
Fortis Healthcare Ltd in the last 5 years
Lowest (-166.21x)
June 25, 2021
Today (61.44x)
July 23, 2024
Industry (90.00x)
July 23, 2024
Highest (165.13x)
April 9, 2020
Fortis Healthcare Ltd’s net profit jumped 34.84% since last year same period to ₹178.73Cr in the Q4 2023-2024. On a quarterly growth basis, Fortis Healthcare Ltd has generated 32.72% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Fortis Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.41%.
Read More about DividendsBearish
Neutral
Bullish
Fortis Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Fortis Healthcare Ltd (FORTIS) share price today is ₹483.05
Fortis Healthcare Ltd is listed on NSE
Fortis Healthcare Ltd is listed on BSE
PE Ratio of Fortis Healthcare Ltd is 61.44
PE ratio = Fortis Healthcare Ltd Market price per share / Fortis Healthcare Ltd Earnings per share
Today’s traded volume of Fortis Healthcare Ltd(FORTIS) is 6.15L.
Today’s market capitalisation of Fortis Healthcare Ltd(FORTIS) is ₹36781.56Cr.
Fortis Healthcare Ltd(FORTIS | Price |
---|---|
52 Week High | ₹509.85 |
52 Week Low | ₹308.5 |
Fortis Healthcare Ltd(FORTIS) share price is ₹483.05. It is down -5.26% from its 52 Week High price of ₹509.85
Fortis Healthcare Ltd(FORTIS) share price is ₹483.05. It is up 56.58% from its 52 Week Low price of ₹308.5
Fortis Healthcare Ltd(FORTIS | Returns |
---|---|
1 Day Returns | -4.15% |
1 Month Returns | 0.45% |
3 Month Returns | 8.27% |
1 Year Returns | 44.98% |